ANI Pharmaceuticals Files 8-K on Financials
Ticker: ANIP · Form: 8-K · Filed: Mar 11, 2025 · CIK: 1023024
| Field | Detail |
|---|---|
| Company | Ani Pharmaceuticals Inc (ANIP) |
| Form Type | 8-K |
| Filed Date | Mar 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
ANI Pharma dropped an 8-K detailing financials and operations.
AI Summary
ANI Pharmaceuticals, Inc. filed an 8-K on March 11, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company, formerly known as BioSante Pharmaceuticals Inc. and Ben Abraham Technologies Inc., is incorporated in Delaware and headquartered in Baudette, Minnesota.
Why It Matters
This 8-K filing provides crucial updates on ANI Pharmaceuticals' financial performance and operational status, which can influence investor decisions.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting financial information and does not indicate any unusual or high-risk events.
Key Numbers
- 001-31812 — SEC File Number (Identifier for the company's filings)
- 58-2301143 — I.R.S. Employer Identification No. (Tax identification number)
Key Players & Entities
- ANI PHARMACEUTICALS, INC. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 210 Main Street West, Baudette, Minnesota 56623 (address) — Principal executive offices
- March 11, 2025 (date) — Date of report
- BIOSANTE PHARMACEUTICALS INC (company) — Former company name
- BEN ABRAHAM TECHNOLOGIES INC (company) — Former company name
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' but does not detail specific figures within the provided text.
When was the earliest event reported in this filing?
The earliest event reported is March 11, 2025.
What is ANI Pharmaceuticals, Inc.'s state of incorporation?
ANI Pharmaceuticals, Inc. is incorporated in Delaware.
What are the principal executive offices of ANI Pharmaceuticals, Inc.?
The principal executive offices are located at 210 Main Street West, Baudette, Minnesota 56623.
What were ANI Pharmaceuticals, Inc.'s former names?
ANI Pharmaceuticals, Inc. was formerly known as BioSante Pharmaceuticals Inc. and Ben Abraham Technologies Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 11, 2025 regarding ANI PHARMACEUTICALS INC (ANIP).